Effect of age on toxicokinetics among human volunteers exposed to propylene glycol methyl ether (PGME).

[1]  D. Vernez,et al.  Sex Differences in Urinary Levels of Several Biological Indicators of Exposure: A Simulation Study Using a Compartmental-Based Toxicokinetic Model , 2014, Journal of occupational and environmental hygiene.

[2]  S. Hilmer,et al.  Age-Related Changes in the Hepatic Pharmacology and Toxicology of Paracetamol , 2011, Current gerontology and geriatrics research.

[3]  B. Danuser,et al.  Sex differences in urinary levels of several biological indicators of exposure: a human volunteer study. , 2011, Toxicology letters.

[4]  Robert F Herrick,et al.  Biomarker variance component estimation for exposure surrogate selection and toxicokinetic inference. , 2010, Toxicology letters.

[5]  M. Bérode,et al.  Sensitive headspace gas chromatography analysis of free and conjugated 1-methoxy-2-propanol in urine , 2010, Analytical and bioanalytical chemistry.

[6]  K. Kang,et al.  Age-related changes in hepatic expression and activity of cytochrome P450 in male rats , 2010, Archives of Toxicology.

[7]  C. Pedone,et al.  Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. , 2010, Current medicinal chemistry.

[8]  Raymond Kohli,et al.  Les scénarios de l'évolution de la population de la Suisse : 2010-2060 , 2010 .

[9]  To Catherine,et al.  Age differences in biological monitoring of chemical exposure: a tentative description using a toxicokinetic model , 2009, International archives of occupational and environmental health.

[10]  M. Kennedy.  Hormonal Regulation of Hepatic Drug‐Metabolizing Enzyme Activity During Adolescence , 2008, Clinical pharmacology and therapeutics.

[11]  E. Eldesoky,et al.  Pharmacokinetic-Pharmacodynamic Crisis in the Elderly , 2007, American journal of therapeutics.

[12]  R. Tardif,et al.  Biological Exposure Indicators: Quantification of Biological Variability Using Toxicokinetic Modeling , 2006, Journal of occupational and environmental hygiene.

[13]  D. Hattis,et al.  Pharmacokinetic and Pharmacodynamic Factors That Can Affect Sensitivity to Neurotoxic Sequelae in Elderly Individuals , 2005, Environmental health perspectives.

[14]  M L Gargas,et al.  Using Physiologically‐Based Pharmacokinetic Modeling to Address Nonlinear Kinetics and Changes in Rodent Physiology and Metabolism Due to Aging and Adaptation in Deriving Reference Values for Propylene Glycol Methyl Ether and Propylene Glycol Methyl Ether Acetate , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[15]  R A Corley,et al.  Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans. , 2005, Toxicology letters.

[16]  R. Sawchuk,et al.  Pharmacokinetics of propylene glycol in the rabbit , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[17]  Vinjar Fønnebø,et al.  Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  W. J. Kollöffel,et al.  Pharmacokinetics of propylene glycol after rectal administration , 1996, Pharmacy World and Science.

[19]  M. Chancellor,et al.  Differential diagnosis and treatment of impaired bladder emptying. , 2004, Reviews in urology.

[20]  Anne Devanthéry.  Toxico-cinétique et surveillance biologique du propylène glycol monométhyl éther , 2003 .

[21]  R. Tardif,et al.  Impact of human variability on the biological monitoring of exposure to toluene, phenol, lead, and mercury: II. Compartmental based toxicokinetic modelling. , 2002, Toxicology letters.

[22]  D. Platt,et al.  The Aging Liver , 2002, Gerontology.

[23]  P. Droz,et al.  Propylene glycol monomethyl ether occupational exposure. 3. Exposure of human volunteers , 2002, International archives of occupational and environmental health.

[24]  K. Krishnan,et al.  Blood:air partition coefficients of individual and mixtures of trihalomethanes. , 2001, Chemosphere.

[25]  P. Droz,et al.  Propylene glycol monomethyl ether (PGME) exposure , 2000 .

[26]  J. Cocker,et al.  Dermal Uptake of Solvents from the Vapour Phase; an Experimental Study in Humans , 1998 .

[27]  H. K. Wilson,et al.  A biological monitoring study of 1-methoxy-2-propanol: analytical method development and a human volunteer study. , 1997, The Science of the total environment.

[28]  R. S. Thomas,et al.  Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. , 1996, American Industrial Hygiene Association journal.

[29]  R. Tardif,et al.  Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air , 1995, International archives of occupational and environmental health.

[30]  G. Herkes,et al.  Studies on the renal excretion of the acyl glucuronide, phenolic glucuronide and sulphate conjugates of diflunisal. , 1993, British journal of clinical pharmacology.

[31]  D. Welte,et al.  Chronic occupational exposure to organic solvents , 1992, International archives of occupational and environmental health.

[32]  Younan Xia,et al.  Biological monitoring of chemical exposures in the workplace , 1992 .

[33]  L. Birnbaum.  Pharmacokinetic basis of age-related changes in sensitivity to toxicants. , 1991, Annual review of pharmacology and toxicology.

[34]  G. Johanson,et al.  Liquid/air partition coefficients of six commonly used glycol ethers. , 1988, British journal of industrial medicine.

[35]  M. Gore,et al.  Propylene Glycol Pharmacokinetics and Effects after Intravenous Infusion in Humans , 1987, Therapeutic drug monitoring.

[36]  R. Miller.  Metabolism and disposition of glycol ethers. , 1987, Drug metabolism reviews.

[37]  R. Miller,et al.  Metabolism and disposition of propylene glycol monomethyl ether (PGME) beta isomer in male rats. , 1986, Toxicology and applied pharmacology.

[38]  W. Elmquist,et al.  Pharmacokinetics of propylene glycol in humans during multiple dosing regimens. , 1985, Journal of pharmaceutical sciences.

[39]  L. Birnbaum,et al.  Age-related changes in glucuronidation and deglucuronidation in liver, small intestine, lung, and kidney of male Fischer rats. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[40]  M. McKenna,et al.  The comparative absorption and excretion of chemical vapors by the upper, lower, and intact respiratory tract of rats. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[41]  O. M. Edwards,et al.  Urinary creatinine excretion as an index of the copleteness of 24-hour urine collections. , 1969, Lancet.

[42]  R. L. Chandler,et al.  HOSPITAL SERVICES FOR THE SUBNORMAL. , 1963, Lancet.